JPH0529039B2 - - Google Patents
Info
- Publication number
- JPH0529039B2 JPH0529039B2 JP60196468A JP19646885A JPH0529039B2 JP H0529039 B2 JPH0529039 B2 JP H0529039B2 JP 60196468 A JP60196468 A JP 60196468A JP 19646885 A JP19646885 A JP 19646885A JP H0529039 B2 JPH0529039 B2 JP H0529039B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- butyloxycarbonyl
- ascamycin
- formula
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60196468A JPS6256500A (ja) | 1985-09-05 | 1985-09-05 | アスカマイシンの合成法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60196468A JPS6256500A (ja) | 1985-09-05 | 1985-09-05 | アスカマイシンの合成法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6256500A JPS6256500A (ja) | 1987-03-12 |
JPH0529039B2 true JPH0529039B2 (enrdf_load_stackoverflow) | 1993-04-28 |
Family
ID=16358302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60196468A Granted JPS6256500A (ja) | 1985-09-05 | 1985-09-05 | アスカマイシンの合成法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6256500A (enrdf_load_stackoverflow) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824657A (en) * | 1997-03-18 | 1998-10-20 | Cubist Pharmaceuticals, Inc. | Aminoacyl sulfamides for the treatment of hyperproliferative disorders |
-
1985
- 1985-09-05 JP JP60196468A patent/JPS6256500A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6256500A (ja) | 1987-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0313239B2 (enrdf_load_stackoverflow) | ||
Castro-Pichel et al. | A facile synthesis of ascamycin and related analogues | |
JPH07206856A (ja) | 5−メチルウリジンを用いる2’,3’−ジデヒドロ−3’−デオキシチミジン(d4T)の大量製造法 | |
EP0287353A2 (en) | Chiral synthesis of anthracyclines from substituted anthraquinones | |
Knapp et al. | Synthesis of protected aminocyclohexanediols | |
JP3029806B2 (ja) | コルヒチン誘導体をグリコシド化する方法、及びその生成物 | |
JPH0529039B2 (enrdf_load_stackoverflow) | ||
EP0350292B1 (en) | Process for preparing 2'-deoxy-beta-adenosine | |
JP3194581B2 (ja) | ジベレリン分離法 | |
JPH06135988A (ja) | ヌクレオシド誘導体 | |
JPS5896098A (ja) | エリスロマイシンa誘導体 | |
JPH08217788A (ja) | 1−n−エチルシソマイシンの製造方法 | |
EP0000656B1 (en) | 4"-ureido-oleandomycin derivatives, process for their preparation and their use in pharmaceutical compositions | |
JPS5936914B2 (ja) | セフアロスポリン類縁体 | |
KR100322355B1 (ko) | 아노머성플루오로리보실아민 | |
KR100393913B1 (ko) | 5-메틸우리딘으로부터디4티를제조하는방법 | |
JPH0529240B2 (enrdf_load_stackoverflow) | ||
IE912762A1 (en) | Process for the preparation of deoxynucleosides | |
KR101259648B1 (ko) | 2′,2′-디플루오로뉴클레오시드 및 중간체의 새로운 제조방법 | |
JPH07165785A (ja) | 3′−フルオロピリミジンヌクレオシド類の製造方法 | |
JPH02292295A (ja) | エトポシドの製造方法 | |
JP2666160B2 (ja) | 5−o−ピリミジル−2,3−ジデオキシ−1−チオフラノシド誘導体,その製造方法及び用途 | |
CN107090009B (zh) | 一种二糖核苷化合物及其制备方法 | |
JPH06135989A (ja) | ヌクレオシド誘導体 | |
US5498719A (en) | Diastereoselective process leading to a key intermediate for the preparation of fluorinated reverse transcriptase inhibitors |